StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Consolidated U.S. Reported Sales Growth YoY by Year

Consolidated U.S. Reported Sales Growth YoY (%) (%)

QuarterlyAnnual

Stryker Consolidated U.S. Reported Sales Growth YoY: 12.2% in FY2025, up 1.2 pts from a year earlier.

Latest, FY2025
12.2%
Period ended Dec 31, 2025
Change on a year earlier
+1.2 pts
11.0% in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

Reported in Stryker Form 8-K Sales Growth Analysis.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated U.S. Reported Sales Growth YoY (%) (%)Year on yearSource
FY2025Dec 31, 202512.2%+1.2 pts0000310764-26-000006|sykex991earningsq42025.htm ↗
FY2024Dec 31, 202411.0%-0.9 pts0000310764-25-000005|sykex991earningsq42024.htm ↗
FY2023Dec 31, 202311.9%+1.2 pts0000310764-24-000005|sykex991earningsq42023.htm ↗
FY2022Dec 31, 202210.7%-1.7 pts0000310764-23-000005|sykex991earningsq42022.htm ↗
FY2021Dec 31, 202112.4%+17.0 pts0000310764-22-000008|sykex991earningsq42021.htm ↗
FY2020Dec 31, 2020-4.6%-15.9 pts0000310764-21-000005|sykex991earningsq42020.htm ↗
FY2019Dec 31, 201911.3%-9047.7 pts0000310764-20-000004|sykex991earningsq42019.htm ↗
FY2018Dec 31, 20189,059.0%–0000310764-19-000006|sykex991earnings1292019.htm ↗

Cite this data

StockData. (2026). Stryker Consolidated U.S. Reported Sales Growth YoY (%), annual FY2018–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-cons-us-rep

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.